AI-generated summary
The authors evaluated photobiomodulation therapy in 16 patients with head and neck cancer who had limited mouth opening during radiotherapy. They report that mouth opening increased by more than 7 mm over treatment and that pain scores decreased. The abstract states that further studies are needed to assess whether the therapy can prevent trismus.
- Participants
- 16
- Who or what was studied
- Patients undergoing radiotherapy for head and neck cancer with mouth opening under 35 mm (10 men, 6 women)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes a small sample with no control group and notes that preventive capacity remains to be evaluated in further studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Energy density (fluence)
- 107 J/cm2
- Power
- 0.1 W
- Total energy
- 3 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Dose, Visual analogue scale, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.